Literature DB >> 26521170

Impairment of ATP hydrolysis decreases adenosine A1 receptor tonus favoring cholinergic nerve hyperactivity in the obstructed human urinary bladder.

M Silva-Ramos1,2,3, I Silva1,2, M Faria1,2, M T Magalhães-Cardoso1,2, J Correia1,2, F Ferreirinha1,2, P Correia-de-Sá4,5.   

Abstract

This study was designed to investigate whether reduced adenosine formation linked to deficits in extracellular ATP hydrolysis by NTPDases contributes to detrusor neuromodulatory changes associated with bladder outlet obstruction in men with benign prostatic hyperplasia (BPH). The kinetics of ATP catabolism and adenosine formation as well as the role of P1 receptor agonists on muscle tension and nerve-evoked [(3)H]ACh release were evaluated in mucosal-denuded detrusor strips from BPH patients (n = 31) and control organ donors (n = 23). The neurogenic release of ATP and [(3)H]ACh was higher (P < 0.05) in detrusor strips from BPH patients. The extracellular hydrolysis of ATP and, subsequent, adenosine formation was slower (t (1/2) 73 vs. 36 min, P < 0.05) in BPH detrusor strips. The A(1) receptor-mediated inhibition of evoked [(3)H]ACh release by adenosine (100 μM), NECA (1 μM), and R-PIA (0.3 μM) was enhanced in BPH bladders. Relaxation of detrusor contractions induced by acetylcholine required 30-fold higher concentrations of adenosine. Despite VAChT-positive cholinergic nerves exhibiting higher A(1) immunoreactivity in BPH bladders, the endogenous adenosine tonus revealed by adenosine deaminase is missing. Restoration of A1 inhibition was achieved by favoring (1) ATP hydrolysis with apyrase (2 U mL(-1)) or (2) extracellular adenosine accumulation with dipyridamole or EHNA, as these drugs inhibit adenosine uptake and deamination, respectively. In conclusion, reduced ATP hydrolysis leads to deficient adenosine formation and A(1) receptor-mediated inhibition of cholinergic nerve activity in the obstructed human bladder. Thus, we propose that pharmacological manipulation of endogenous adenosine levels and/or A(1) receptor activation might be useful to control bladder overactivity in BPH patients.

Entities:  

Keywords:  ATP catabolism; Acetylcholine release; Adenosine A1 receptors; Bladder outlet obstruction; Ectonucleotidases; Human urinary bladder

Mesh:

Substances:

Year:  2015        PMID: 26521170      PMCID: PMC4648796          DOI: 10.1007/s11302-015-9478-z

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  50 in total

1.  Regulation of bladder muscarinic receptor subtypes by experimental pathologies.

Authors:  M R Ruggieri; A S Braverman
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

2.  Effect of exogenous adenosine and its monophosphate on the contractile response to acetylcholine in the human isolated detrusor muscle strips.

Authors:  R Rubinstein; M Shalev; I Nissenkorn; S Cohen
Journal:  J Auton Pharmacol       Date:  1998-04

3.  Tissue distribution of adenosine receptor mRNAs in the rat.

Authors:  A K Dixon; A K Gubitz; D J Sirinathsinghji; P J Richardson; T C Freeman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase.

Authors:  Paulo Correia-de-Sá; Sara Adães; M Alexandrina Timóteo; Cátia Vieira; Teresa Magalhães-Cardoso; Carlos Nascimento; Margarida Duarte-Araújo
Journal:  Auton Neurosci       Date:  2006-03-06       Impact factor: 3.145

5.  Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens.

Authors:  J Gonçalves; G Queiroz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

6.  Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Neuroscience       Date:  1996-07       Impact factor: 3.590

7.  Purinergic modulation of rat urinary bladder detrusor smooth muscle.

Authors:  J A King; H Huddart; W G Staff
Journal:  Gen Pharmacol       Date:  1997-10

8.  A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders.

Authors:  M Bayliss; C Wu; D Newgreen; A R Mundy; C H Fry
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

9.  Pharmacological characterization of adenosine A1 and A2 receptors in the bladder: evidence for a modulatory adenosine tone regulating non-adrenergic non-cholinergic neurotransmission.

Authors:  C G Acevedo; E Contreras; J Escalona; J Lewin; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

10.  Low energy charge and high adenosine content in smooth muscle of human bladder in comparison with striated muscle.

Authors:  K Wedenberg; G Ronquist; A Waldenström; U Ulmsten
Journal:  Int J Clin Lab Res       Date:  1994
View more
  10 in total

1.  Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release.

Authors:  Giselle Bravo; Helen Massa; Roselyn Rose'Meyer; Russ Chess-Williams; Catherine McDermott; Donna J Sellers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-11       Impact factor: 3.000

Review 2.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

3.  β3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release.

Authors:  Isabel Silva; M Teresa Magalhães-Cardoso; Fátima Ferreirinha; Sílvia Moreira; Ana Filipa Costa; Diogo Silva; Cátia Vieira; Miguel Silva-Ramos; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

4.  Characterisation of nerve-mediated ATP release from bladder detrusor muscle and its pathological implications.

Authors:  Carly J McCarthy; Youko Ikeda; Deborah Skennerton; Basu Chakrabarty; Anthony J Kanai; Rita I Jabr; Christopher H Fry
Journal:  Br J Pharmacol       Date:  2019-11-03       Impact factor: 8.739

5.  Targetable purinergic receptors P2Y12 and A2b antagonistically regulate bladder function.

Authors:  Yuan Hao; Lu Wang; Huan Chen; Warren G Hill; Simon C Robson; Mark L Zeidel; Weiqun Yu
Journal:  JCI Insight       Date:  2019-08-22

Review 6.  Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.

Authors:  Andréia Machado Cardoso; Mauro Nicollas Oliveira Silvério; Sarah Franco Vieira de Oliveira Maciel
Journal:  Purinergic Signal       Date:  2021-09-29       Impact factor: 3.765

7.  Association between Age and Changes in Heart Rate Variability after Hemodialysis in Patients with Diabetes.

Authors:  Sheng-Wen Niu; Jiun-Chi Huang; Szu-Chia Chen; Hugo Y-H Lin; I-Ching Kuo; Pei-Yu Wu; Yi-Wen Chiu; Jer-Ming Chang
Journal:  Front Aging Neurosci       Date:  2018-02-20       Impact factor: 5.750

8.  Urinary ATP may be a biomarker for bladder outlet obstruction and its severity in patients with benign prostatic hyperplasia.

Authors:  Zhenghao Chen; Yaxiao Liu; Mengmeng Zhao; Shulu Zu; Yan Li; Benkang Shi; Shaoyong Wang; Xiulin Zhang
Journal:  Transl Androl Urol       Date:  2020-04

9.  The role of ATP signalling in response to mechanical stimulation studied in T24 cells using new microphysiological tools.

Authors:  Na N Guan; Nimish Sharma; Katarina Hallén-Grufman; Edwin W H Jager; Karl Svennersten
Journal:  J Cell Mol Med       Date:  2018-02-01       Impact factor: 5.310

10.  Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers.

Authors:  Carina Herman-de-Sousa; Ana Rita Pinheiro; Diogo Paramos-de-Carvalho; Maria Adelina Costa; Fátima Ferreirinha; Teresa Magalhães-Cardoso; Severino Ribeiro; Julie Pelletier; Jean Sévigny; Paulo Correia-de-Sá
Journal:  Cells       Date:  2020-03-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.